Voyageur Pharmaceuticals (TSXV:VM) Other Net Income (Loss) : C$0.00 Mil (TTM As of Feb. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Voyageur Pharmaceuticals Other Net Income (Loss)?

Voyageur Pharmaceuticals's Other Net Income (Loss) for the three months ended in Feb. 2024 was C$0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Feb. 2024 was C$0.00 Mil.

Voyageur Pharmaceuticals Other Net Income (Loss) Historical Data

The historical data trend for Voyageur Pharmaceuticals's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voyageur Pharmaceuticals Other Net Income (Loss) Chart

Voyageur Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Other Net Income (Loss)

Get a 7-Day Free Trial

Voyageur Pharmaceuticals Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Voyageur Pharmaceuticals Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Voyageur Pharmaceuticals Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Voyageur Pharmaceuticals's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Voyageur Pharmaceuticals (TSXV:VM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Voyageur Pharmaceuticals Ltd (TSXV:VM) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

VYYRF:USA

Address

333 Southwest 7th Avenue, Suite 800, Calgary, AB, CAN, T2P 2Z1

Website

https://www.voyageurpharmaceuticals.ca

Voyageur Pharmaceuticals Ltd is engaged in the development of pharmaceutical ingredients (API) minerals. The company focuses on developing barium and iodine radiocontrast products and bromine-based pharmaceutical products. It provides its products for medical applications and diagnostics.

Executives

Charles Littlejohn

10% Security Holder

Voyageur Pharmaceuticals (TSXV:VM) Headlines

No Headlines